Skip to main content

Timothy Sterling Archives

Grants enhance Tuberculosis Center’s global research efforts

Nov. 10, 2016—Since July, investigators in the Vanderbilt Tuberculosis Center have been awarded research grants totaling $5 million.

Read more


HIV treatment and TB risk

Aug. 4, 2016—Tuberculosis (TB) remains an important public health problem, particularly among people infected with the human immunodeficiency virus (HIV).

Read more


Preserving antibiotic arsenal for TB

Oct. 30, 2013—Clinicians should be cautious about prescribing newer fluoroquinolone antibiotics to patients with TB risk factors; doing so may jeopardize the use of these agents against TB.

Read more


New center to focus on treating, preventing TB

Mar. 14, 2013—Vanderbilt University has established a tuberculosis center to expand and extend efforts to improve the treatment and prevention of this often fatal disease here and around the world.

Read more


Early HIV treatment also can prevent TB: study

Aug. 2, 2012—Anti-retroviral therapy can prevent tuberculosis, even in people with early HIV disease.

Read more


Study leads to simpler therapy for treating latent tuberculosis

Dec. 9, 2011—Research led by Timothy Sterling, professor of medicine, has led to an important change in The Centers for Disease Control and Prevention's recommendations in the regimen for prevention of the centuries-old scourge, tuberculosis.

Read more


Investigator’s work leads to simpler latent TB therapy

Jul. 29, 2011—New research on tuberculosis offers an important development in preventing the centuries-old disease.

Read more